(Q82651872)
Statements
Discovery and characterization of taspoglutide, a novel analogue of human glucagon-like peptide-1, engineered for sustained therapeutic activity in type 2 diabetes (English)
J Z Dong
Y Shen
J Zhang
N Tsomaia
D F Mierke
1 January 2011